YU47791B - PROCEDURE FOR OBTAINING DIDEOXYCHIDROCAR-BOCYCLIC NUCLEOSIDES - Google Patents

PROCEDURE FOR OBTAINING DIDEOXYCHIDROCAR-BOCYCLIC NUCLEOSIDES

Info

Publication number
YU47791B
YU47791B YU12389A YU12389A YU47791B YU 47791 B YU47791 B YU 47791B YU 12389 A YU12389 A YU 12389A YU 12389 A YU12389 A YU 12389A YU 47791 B YU47791 B YU 47791B
Authority
YU
Yugoslavia
Prior art keywords
formula
substituent
hydrogen
dideoxychidrocar
bocyclic
Prior art date
Application number
YU12389A
Other languages
Serbo-Croatian (sh)
Serbian (sr)
Other versions
YU12389A (en
Inventor
R.. Vince
M. Hua
P.L. Myers
R. Storer
Original Assignee
Regents Of The University Of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Regents Of The University Of Minnesota filed Critical Regents Of The University Of Minnesota
Priority to SI8910123A priority Critical patent/SI8910123A/en
Publication of YU12389A publication Critical patent/YU12389A/en
Publication of YU47791B publication Critical patent/YU47791B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

POSTUPAK ZA DOBIJANJE DIDEOKSIHIDROKAR-BOCIKLICNIH NUKLEOZIDA formule (I): u kojoj je X vodonik, NRR1, SR, OR ili halogen; Z je vodonik OR2 ili NRR1; R, R1 i R2 mogu biti isti ili razliciti i odabrani su medu vodonikom, C1-4alkil i aril; i njihovih farmaceutskih prihvatljivih derivata, naznacen time, sto obuhvata: (A) reakciju jedinjenja formule (II) u kojoj su X i Z definisani kao u formuli (I) ili su njihovi zasticeni oblici, i Y je OH ili njen zasticeni oblik, sa reagensom odabranim medu mravljom kiselinom ili njenim reaktivnim derivatima, posle cega se, ako je potrebno, vrsiti uklanjanje nezeljenih grupa uvedenih pomenutim reagensom i/ili uklanjanje ma kojih prisutnih zastitnih grupa; ili (B) interkonverziju jednog jedinjenja formule (I) ili njegovog zasticenog oblika u drugo jedinjenje formule (I) zamenjivanjem supstituenta X razlicitim supstituentom X i/ili zamenjivanjem supstituenta Z drugim supstituentom Z, posle cega se, ako je potrebno vrsi uklanjanje ma kojih prisutnih zastitnih grupa. Prijava sadrzi jos 16 zavisnih zahteva.A process for the preparation of DIDEOXYCHIDROCAR-BOCYCLIC NUCLEOSIDES of formula (I): wherein X is hydrogen, NRR1, SR, OR or halogen; Z is hydrogen OR2 or NRR1; R, R1 and R2 may be the same or different and are selected from hydrogen, C1-4alkyl and aryl; and their pharmaceutically acceptable derivatives, comprising: (A) a reaction of a compound of formula (II) in which X and Z are defined as in formula (I) or are protected forms thereof, and Y is OH or a protected form thereof, with a reagent selected from formic acid or its reactive derivatives, followed, if necessary, by removing the undesired groups introduced by said reagent and / or removing any protecting groups present; or (B) the interconversion of one compound of formula (I) or its protected form to another compound of formula (I) by replacing substituent X with a different substituent X and / or replacing substituent Z with another substituent Z, and subsequently removing any present if necessary protection groups. The application contains 16 more dependent requests.

YU12389A 1988-01-20 1989-01-19 PROCEDURE FOR OBTAINING DIDEOXYCHIDROCAR-BOCYCLIC NUCLEOSIDES YU47791B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SI8910123A SI8910123A (en) 1988-01-20 1989-01-19 Dideoxy-dihydro-carbocyclic nucleosides

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (2)

Publication Number Publication Date
YU12389A YU12389A (en) 1991-10-31
YU47791B true YU47791B (en) 1996-01-09

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
YU12389A YU47791B (en) 1988-01-20 1989-01-19 PROCEDURE FOR OBTAINING DIDEOXYCHIDROCAR-BOCYCLIC NUCLEOSIDES

Country Status (29)

Country Link
JP (1) JP2793825B2 (en)
KR (1) KR0127137B1 (en)
AT (1) AT397801B (en)
AU (2) AU626278B2 (en)
BE (1) BE1003815A4 (en)
CA (1) CA1339896C (en)
CH (1) CH679152A5 (en)
DE (1) DE3901502C2 (en)
DK (1) DK175131B1 (en)
ES (1) ES2010091A6 (en)
FI (1) FI93546C (en)
FR (1) FR2626002B1 (en)
GB (1) GB2217320B (en)
GR (1) GR890100033A (en)
HU (1) HU203755B (en)
IE (1) IE62275B1 (en)
IL (1) IL88999A (en)
IT (1) IT1229531B (en)
LU (1) LU87437A1 (en)
MY (1) MY103801A (en)
NL (1) NL8900122A (en)
NO (1) NO169123C (en)
NZ (1) NZ227663A (en)
OA (1) OA09031A (en)
PL (1) PL163814B1 (en)
PT (1) PT89482B (en)
RU (1) RU2114846C1 (en)
SE (1) SE505213C2 (en)
YU (1) YU47791B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (en) * 1987-01-14 1990-02-08 Co Pharma Corp Srl PROCEDURE FOR THE PREPARATION OF 9- (HYDROXIALCHIL) -IPOXANTINE
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
JP3164361B2 (en) * 1989-06-27 2001-05-08 ザ ウエルカム ファウンデーション リミテッド Therapeutic nucleoside
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
CN1137274A (en) * 1993-11-12 1996-12-04 默里尔药物公司 6-oxo-nucleosides useful as immunosuppressants
GB9721780D0 (en) 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
DE59905679D1 (en) 1998-10-30 2003-06-26 Lonza Ag METHOD FOR PRODUCING 4 - [(2 ', 5'-DIAMINO-6'-HALOGENPYRIMIDIN-4'-YL) AMINO] -CYCLOPENT-2-ENYLMETHANOLS
AU1158000A (en) * 1998-10-30 2000-05-22 Lonza A.G. Method for producing 4- ((2',5'- diamino-6'- halopyrimidine- 4'-YL)amino)- cyclopent- 2-enylmethanols
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (en) 2002-05-13 2005-02-23 Tibotec Pharm Ltd MICROBICIDE COMPOUNDS WITH PIRIMIDINE OR TRIAZINE CONTENT
JP7104154B2 (en) 2018-07-27 2022-07-20 富士フイルム株式会社 Cyclopentenylpurine derivative or salt thereof
WO2021191417A1 (en) 2020-03-27 2021-09-30 Som Innovation Biotech, S.A. Compounds for use in the treatment of synucleinopathies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (en) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd Production device of carbon fiber by centrifugal spinning
IN164556B (en) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
SE505213C2 (en) 1997-07-14
DK23489A (en) 1989-07-21
LU87437A1 (en) 1989-08-30
GR890100033A (en) 1994-03-31
FI890286A0 (en) 1989-01-19
GB8901187D0 (en) 1989-03-15
JP2793825B2 (en) 1998-09-03
NO169123C (en) 1992-05-13
AT397801B (en) 1994-07-25
FI890286A (en) 1989-07-21
NL8900122A (en) 1989-08-16
BE1003815A4 (en) 1992-06-23
AU2867189A (en) 1989-07-20
DE3901502C2 (en) 2002-06-13
FI93546B (en) 1995-01-13
HU203755B (en) 1991-09-30
YU12389A (en) 1991-10-31
AU1018092A (en) 1992-03-12
PL163814B1 (en) 1994-05-31
CA1339896C (en) 1998-06-02
DE3901502A1 (en) 1989-07-27
NO890253D0 (en) 1989-01-19
IT8947546A0 (en) 1989-01-19
FI93546C (en) 1995-04-25
ES2010091A6 (en) 1989-10-16
ATA10689A (en) 1993-11-15
IT1229531B (en) 1991-09-04
NO169123B (en) 1992-02-03
FR2626002A1 (en) 1989-07-21
HUT48887A (en) 1989-07-28
SE8900192D0 (en) 1989-01-19
AU637015B2 (en) 1993-05-13
SE8900192L (en) 1989-07-21
KR0127137B1 (en) 1997-12-29
IE62275B1 (en) 1995-01-25
KR890011902A (en) 1989-08-23
JPH02196788A (en) 1990-08-03
IL88999A0 (en) 1989-08-15
OA09031A (en) 1991-03-31
CH679152A5 (en) 1991-12-31
IE890153L (en) 1989-07-20
PT89482A (en) 1989-10-04
PT89482B (en) 1994-02-28
FR2626002B1 (en) 1994-01-28
GB2217320A (en) 1989-10-25
NZ227663A (en) 1990-09-26
NO890253L (en) 1989-07-21
MY103801A (en) 1993-09-30
RU2114846C1 (en) 1998-07-10
DK175131B1 (en) 2004-06-14
GB2217320B (en) 1992-04-08
AU626278B2 (en) 1992-07-30
PL277261A1 (en) 1989-09-18
IL88999A (en) 1994-12-29
DK23489D0 (en) 1989-01-19

Similar Documents

Publication Publication Date Title
YU47791B (en) PROCEDURE FOR OBTAINING DIDEOXYCHIDROCAR-BOCYCLIC NUCLEOSIDES
TW377356B (en) Process for purifying and isolating beta-anomer enriched 2'-deoxy-2',2'-difluoronucleosides
ES483629A1 (en) Novel naphtyridine derivatives and pharmaceutical compositions containing them.
SE8107273L (en) 2-OXOAZETIDE DERIVATIVES, SET TO PREPARE DEMOCH USE THEREOF
ES8606381A1 (en) Novel 2'-deoxy-5-substituted uridine derivatives, processes for preparing the same and antitumor agent containing the same.
ES8506726A1 (en) Novel cephalosporin compound and a process for preparing same.
ES2092962A1 (en) Nitric esters of 2-(2,6-dihalophenylamino) phenylacetoxyacetic acid derivatives and their preparation process
NO964735L (en) Adenosine derivatives
JPS57146798A (en) Hexosyl nucleoside derivative
JPS5440054A (en) Information process system
ES428442A1 (en) 1,2,3,4-tetrahydroisoquinoline derivatives and the preparation thereof
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
JPS57114516A (en) Inhibitor of phosphodiesterase reaction
ES392906A1 (en) Procedure for the preparation of benzensulfonil urea compounds. (Machine-translation by Google Translate, not legally binding)
BG60207B2 (en) Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides
TH5201EX (en) 7 - ((metha-substrate) phenylglycine) 1-carba-1-dithiacephalosporins
JPS55136281A (en) Xanthine derivative
ES8303428A1 (en) A procedure to prepare new cefem compounds. (Machine-translation by Google Translate, not legally binding)
ES8303319A1 (en) A procedure to obtain biciclooctan derivatives. (Machine-translation by Google Translate, not legally binding)
ES474955A1 (en) A procedure for the preparation of a polyclical compound. (Machine-translation by Google Translate, not legally binding)
JPS57149294A (en) Phosphoroamidate derivative, its preparation, phosphorylation agent therefrom and its use
JPS5271484A (en) Synthesis of novel quinazoline derivatives
JPS5227780A (en) Preparation of 2;3'-lixoepithiouridine
YU46713B (en) PROCEDURE FOR OBTAINING NEW MICROLIDE COMPOUNDS
JPS52113944A (en) N-halogenobenzul-n-alkyl-n-phenyl-(thio)-ureas, preparation of the sa me, and method of combatting plant infections by using the same